Form 4: LivePerson Director Vardeman Granted 23,350 RSUs

LivePerson, Inc. Director Ryan L. Vardeman was granted 23,350 restricted stock units, scheduled to vest fully on December 10, 2026.

Summary

• Director Ryan L. Vardeman was granted 23,350 restricted stock units (RSUs) under the LivePerson, Inc. 2019 Stock Incentive Plan.
• Each RSU represents a contingent right to receive one share of common stock of the issuer.
• These RSUs are scheduled to fully vest on December 10, 2026.
• Following this transaction, Vardeman directly holds 23,350 securities, which include these unvested RSUs.
• Vardeman also indirectly beneficially owns 44,422 shares of common stock through various Palogic entities.
• Vardeman disclaims beneficial ownership of the indirectly held securities except to the extent of his pecuniary interest.

Sentiment

Score: 6

Explanation: The grant of RSUs is a positive for aligning director interests with shareholders, but the future transaction date and disclaimers on beneficial ownership introduce minor complexities. It's a routine compensation event.

Positives

• The grant of 23,350 restricted stock units aligns the director's interests with long-term shareholder value.
• The grant is part of the company's 2019 Stock Incentive Plan, indicating a structured approach to executive compensation.

Negatives

• The RSUs are unvested and represent a contingent right, meaning the shares are not immediately owned or liquid.
• The reporting person disclaims beneficial ownership of a significant portion of the reported securities (44,422 shares held indirectly), except for his pecuniary interest.

Risks

• The value of the RSUs is contingent on the future stock price of LivePerson, Inc.
• The reporting person disclaims full beneficial ownership of indirectly held securities, which could complicate future analyses of insider holdings.

Future Outlook

The grant of restricted stock units to Director Ryan L. Vardeman is structured to vest fully on December 10, 2026, aligning his compensation with the company's future performance over the next year.

Industry Context

This transaction reflects a common practice in the technology and growth sectors where companies utilize equity-based compensation, such as restricted stock units, to attract, retain, and incentivize directors and executives. Such grants aim to align leadership's long-term interests with shareholder value creation, a prevalent strategy across publicly traded companies.

Related Party Transactions

• Ryan L. Vardeman's indirect beneficial ownership of 44,422 shares is through entities (Palogic Value Fund, Palogic Value Management, Palogic Capital Management) where he holds significant roles (sole member, limited partner), indicating related party dealings in terms of share ownership structure.

Stakeholder Impact

• Shareholders: The RSU grant aligns director incentives with long-term shareholder value.

Next Steps

• The 23,350 restricted stock units are scheduled to fully vest on December 10, 2026.

Key Dates

Recommendation

This Form 4 filing details a routine equity grant to a director, which is a standard compensation practice and does not provide new fundamental information to warrant a change in investment recommendation. The grant aligns the director's interests with long-term shareholder value, which is generally positive, but it's not a catalyst for a 'buy' or 'sell' decision.

Keywords

LivePerson, LPSN, Form 4, Restricted Stock Units, RSU, Insider Transaction, Beneficial Ownership, Director Compensation, Stock Incentive Plan